Market Tracker

09/26 8:00am ET

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

6.41
Delayed Data
As of Sep 23
 +0.15 / +2.40%
Today’s Change
5.18
Today|||52-Week Range
11.26
-38.19%
Year-to-Date
Here's Why TherapeuticsMD Inc. Fell 11.5% in August
Sep 12 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close6.26
Today’s open6.26
Day’s range6.18 - 6.43
Volume1,912,065
Average volume (3 months)1,285,835
Market cap$1.3B
Dividend yield--
Data as of 09/23/2016

Growth & Valuation

Earnings growth (last year)-36.11%
Earnings growth (this year)+12.24%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+34.05%
P/E ratioNM
Price/Sales89.15
Price/Book18.09

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...+0.06+0.22%
INVAInnoviva Inc+0.01+0.09%
SUPNSupernus Pharmaceuti...+0.15+0.58%
CEMPCempra Inc+0.61+2.48%
Data as of 09/23/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$20.1M
Annual profit (last year)-$85.1M
Net profit margin-422.37%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts